Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05918185 · ClinicalTrials.gov registry record
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 56
- Enrollment target
NCT05918185: Completed study, sponsored by Mayo Clinic.
NCT05918185 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05918185 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
This study evaluates the association between a comprehensive geriatric assessment and laboratory biomarkers with the side effects of chemotherapy in older patients with multiple myeloma (MM). The comprehensive geriatric assessment is a tool that can help to determine how fit a patient is. It is composed of a series of questions and tests designed for older people to evaluate their physical function, mental status, mental health, nutritional status, social support, level of social activity, and the presence of other medical problems. In addition to geriatric assessment domains, laboratory biomarkers may provide information on physiologic dysfunction as a measure for evaluation of frailty in the cancer setting. This study will help researchers in the future by predicting which patients will have more side effects with chemotherapy based on their comprehensive geriatric assessment and laboratory biomarkers, which will allow adjustments to treatment in older adult patients with MM.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- OTHER Comprehensive Geriatric Assessment
- OTHER Electronic Health Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-02-15 |
| Est. Completion | 2025-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05918185
The ClinicalTrials.gov registry entry for NCT05918185 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT05918185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05918185 about?
NCT05918185 is a clinical study titled "Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma". This study evaluates the association between a comprehensive geriatric assessment and laboratory biomarkers with the side effects of chemotherapy in older patients with multiple myeloma (MM). The comprehensive geriatric assessment is a tool that can help to determine how fit a patient is. It is comp...
What is the current status of trial NCT05918185?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2023-02-15. Estimated completion is 2025-08-30.
What interventions are being tested in trial NCT05918185?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Comprehensive Geriatric Assessment (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT05918185?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.